Search the web
Sign In
New User? Sign Up
Tourette-Updates · Tourette's Syndrome Disorder
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Message search is now enhanced, find messages faster. Take it for a spin.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Text of Antidepressants Warning   Message List  
Reply | Forward Message #52 of 94 |

Food and Drug Administration (FDA) asks manufacturers of all
antidepressant drugs to include in their labeling a boxed warning
and expanded warning statements that alert health care providers to
an increased risk of suicidality (suicidal thinking and behavior) in
children and adolescents being treated with these agents, and
additional information about the results of pediatric studies.


Text of the "black box" warning that the Food and Drug
Administration ordered included on all antidepressants:

Antidepressants increase the risk of suicidal thinking and behavior
(suicidality) in children and adolescents with major depressive
disorder (MDD) and other psychiatric disorders. Anyone considering
the use of (drug name) or any other antidepressant in a child or
adolescent must balance this risk with the clinical need. Patients
who are started on therapy should be observed closely for clinical
worsening, suicidality, or unusual changes in behavior. Families and
caregivers should be advised of the need for close observation and
communication with the prescriber. (Drug name) is not approved for
use in pediatric patients except for patients with (approved
pediatric claim).

Pooled analyses of short-term (four to 16 weeks) placebo-controlled
trials of nine antidepressant drugs (SSRIs and others) in children
and adolescents with MDD, obsessive compulsive disorder (OCD), or
other psychiatric disorders (a total of 24 trials involving over
4,400 patients) have revealed a greater risk of adverse events
representing suicidal thinking or behavior (suicidality) during the
first few months of treatment in those receiving antidepressants.
The average risk of such events on drug was 4 percent, twice the
placebo risk of 2 percent. No suicides occurred in these trials.

http://www.fda.gov/cder/drug/antidepressants/default.htm

---------------
Paul Marshall
editor@...

http://www.tourettes-disorder.com

Our Tourette Updates List

Relevant, new updates & breakthroughs about Tourette Syndrome -
Tourette Spectrum Disorders. Notices only, not a discussion forum.
Notices about once a month.

To subscribe via e-mail, send a blank e-mail to:
Tourette-Updates-subscribe@yahoogroups.com

To subscribe via the web click here:
http://groups.yahoo.com/group/Tourette-Updates/join?referer=1

To just visit and take a look click here:
http://groups.yahoo.com/group/Tourette-Updates/







Sat Oct 16, 2004 8:57 pm

paul_tourett...
Offline Offline
Send Email Send Email

Forward
Message #52 of 94 |
Expand Messages Author Sort by Date

Food and Drug Administration (FDA) asks manufacturers of all antidepressant drugs to include in their labeling a boxed warning and expanded warning statements...
Paul Marshall
paul_tourett...
Offline Send Email
Oct 16, 2004
8:57 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help